News | Womens Cardiovascular Health | February 09, 2022

SCAI Releases Expert Consensus on Gender-specific Considerations in Myocardial Revascularization

Figure 1Recommended Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention. ∗While not marketed in the United States, DCBs are available for clinical use in Canada, with 1-3 months of DAPT recommended. DAPT = dual antiplatelet therapy; LD, limited data. Reprinted from Capodanno D, Alfonso F, Levine GN, Valgimigli M, Angiolillo DJ. ACC/AHA versus ESC guidelines on dual antiplatelet therapy: JACC guideline comparison. J Am Coll Cardiol. 2018;72(23 Pt A):2915-2931, with permission from

February 9, 2022 — A newly released expert consensus statement on sex-specific considerations in myocardial revascularization aims to summarize available literature on myocardial revascularization in women and identify important gaps in evidence. The document was published today in the Journal of the Society for Cardiovascular Angiography & Interventions (JSCAI), the official journal of SCAI.

Cardiovascular disease is the leading cause of death and disability in women globally, claiming the lives of nearly 8.5 million women each year. Utilization of cardiovascular procedures is far lower in women than men, and women continue to be underrepresented in cardiovascular clinical trials, severely limiting the opportunity to better understand sex differences in cardiovascular drug or device outcomes. Current practice guidelines do not address gender-based differences and fail to highlight when insufficient evidence exists regarding cardiovascular outcomes in women, resulting in overall poorer outcomes.

“This consensus is an international collaborative effort that highlights the knowns, the gaps and ambiguities in evidence related to sex-specific revascularization,” said Alexandra Lansky, MD, FSCAI, Chair of the document, Professor of Medicine in the section of Cardiology at the Yale School of Medicine and a practicing cardiologist at Yale-New Haven Hospital. Lansky is also Editor-in-Chief of JSCAI.  “As a companion to the recent percutaneous coronary intervention (PCI) guidelines, it will inform clinicians on best practices most relevant to our female patients and draws attention to areas in need of additional evidence,” Lansky continued. 

The paper explores gaps in evidence in several areas including the epidemiology of ischemic heart disease, diagnostic tools to guide coronary revascularization, revascularization for chronic coronary syndromes, revascularization for non-ST-elevation myocardial infarction (MI) and ST-elevation MI, and revascularization consideration for specific patient populations, vascular access in women, and more.

“Physicians can use this consensus document to inform their discussions with female patients on the risks and benefits of coronary revascularization,” said J. Dawn Abbott, MD, FSCAI, Co-Chair of the document and Professor of Medicine and Director of the Interventional Cardiology Fellowship Training Program at Brown Medical School. “An understanding of the limitations of the data is important in this regard,” Abbott concluded. 

Authors of the paper state that while the evidence supporting clinical decisions in women is lacking, these findings are important to guide prospective investigation and establish research priorities. 

For more information: www.scai.org

Related Content

News | Womens Cardiovascular Health

May 18 2022 — Older breast cancer survivors with cardiometabolic risk factors who restricted food intake to eight hours ...

Home May 18, 2022
Home
News | Womens Cardiovascular Health

May 11, 2022 — Women who experienced complications related to developing high blood pressure, or hypertension, during ...

Home May 11, 2022
Home
News | Womens Cardiovascular Health
April 25, 2022 – Advancements in techniques and treatment have transformed care for patients with cardiovascular disease ...
Home April 25, 2022
Home
News | Womens Cardiovascular Health
April 21, 2022 – Despite a similar prevalence of the chronic condition, women diagnosed with heart failure have worse ...
Home April 21, 2022
Home
News | Womens Cardiovascular Health

April 20, 2022 – A new study finds that a history of infertility is associated with increased risk of heart failure ...

Home April 20, 2022
Home
News | Womens Cardiovascular Health
March 25, 2022 – In the first study to examine differences by sex and race in outcomes following the seven most common ...
Home March 25, 2022
Home
News | Womens Cardiovascular Health
March 9, 2022 – Poor heart health, especially among women of color, puts both mothers-to-be and their infants at risk ...
Home March 09, 2022
Home
News | Womens Cardiovascular Health

February 28, 2022 — A new collection of scientific articles published today shines a light on the differences between ...

Home February 28, 2022
Home
News | Womens Cardiovascular Health

June 29, 2021 – Three research studies presented at the American Society of Echocardiography (ASE) 2021 virtual meeting ...

Home June 29, 2021
Home
News | Womens Cardiovascular Health

March 8, 2021 — University of Kansas Health System Cardiologist Ashley Simmons, M.D., knew there could and should be a ...

Home March 08, 2021
Home
Subscribe Now